Home

Press Releases

12345678910
American National Completes Full Redemption of Outstanding Depositary Shares Representing Interests in its 6.625% Fixed-Rate Reset Non-Cumulative Preferred Stock, Series B
HOUSTON, Oct. 06, 2025 (GLOBE NEWSWIRE) -- American National Group Inc. (the “Company”) (NYSE: ANG PRB) today announced that the Company has completed the previously announced redemption (the “Redemption”) of all the 12,000 outstanding shares of its 6.625% Fixed-Rate Reset Non-Cumulative Preferred Stock, Series B (the “Series B Preferred Stock”) and the corresponding 12,000,000 depositary shares, each representing a 1/1,000th interest in one share of Series B Preferred Stock (the “Depositary Shares”). The redemption price for the Depositary Shares was $25.00 per Depositary Share (equivalent to $25,000 per share of Series B Preferred Stock) plus an amount equal to any declared but unpaid dividends and the portion of the quarterly dividend attributable to 1/1,000th of a share of Series B Preferred Stock to the then-current dividend period that has not been declared and paid to, but excluding, the redemption date (which was October 6, 2025) (the “Redemption Date”, and such redemption price, the “Redemption Price”). The Company funded the Redemption Price with the net proceeds from its previously announced sale of $500,000,000 aggregate principal amount of the Company’s 7.000% Fixed-Rate Reset Junior Subordinated Notes due 2055.
By American National Group Inc. · Via GlobeNewswire · October 6, 2025
Hongli Group Inc. Announces Compliance with Nasdaq Minimum Bid Price Requirement
WEIFANG, CHINA, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Hongli Group Inc. (Nasdaq: HLP) (the “Company”) today announces that on October 3, 2025, the Company received a notification letter from Nasdaq Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”), dated October 2, 2025, stating that the Company has regained compliance with the requirement to maintain a minimum bid price of $1.00 per share of its Ordinary Shares for continued listing on The Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). Nasdaq made this determination of compliance after the closing bid price of the Company’s ordinary shares (“Ordinary Shares”) has been trading at $1.00 per share or greater for the last 12 consecutive business days from September 16, 2025 to October 1, 2025. Accordingly, Nasdaq has considered that the Company has regained compliance with the Minimum Bid Price Requirement and this matter has been resolved.
By Hongli Group Inc. · Via GlobeNewswire · October 6, 2025
AARO Updates Documents and Implications of Residence-Based Taxation
Via PRLog · October 6, 2025
Lamar Advertising Company to Release Third Quarter Ended September 30, 2025 Operating Results
BATON ROUGE, La., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Lamar Advertising Company (Nasdaq: LAMR) will release its third quarter ended September 30, 2025 earnings report before the market opens on Thursday, November 6, 2025. Lamar will host a conference call on Thursday, November 6, 2025 at 8:00 a.m. (Central time) to discuss the Company’s results and answer questions relating to company operations.
By Lamar Advertising Company · Via GlobeNewswire · October 6, 2025
KBRA Assigns Preliminary Ratings to New Residential Mortgage Loan Trust 2025-NQM5 (NRMLT 2025-NQM5)
KBRA assigns preliminary ratings to 8 classes of mortgage-backed notes from New Residential Mortgage Loan Trust 2025-NQM5 (NRMLT 2025-NQM5), a $500.9 million non-prime RMBS transaction sponsored by Rithm Capital Corp. (formerly New Residential Investment Corp.), a publicly traded (NYSE: RITM) real estate investment trust (REIT). The underlying mortgages in the subject pool were primarily originated by Champions Funding, LLC (31.9%), NewRez LLC (24.8%), and Home Express Mortgage Corp. (15.3%). In addition, all loans will be serviced by Shellpoint Mortgage Servicing, a brand of NewRez LLC.
By Kroll Bond Rating Agency, LLC · Via Business Wire · October 6, 2025
KBRA Assigns Preliminary Ratings to Uniti Fiber ABS Issuer LLC and Uniti Fiber TRS Issuer LLC, Series 2025-2
KBRA assigns preliminary ratings to Series 2025-2 (Uniti 2025-2, or the Series 2025-2 Notes) from Uniti Fiber ABS Issuer LLC (the Lead Issuer) and Uniti Fiber TRS Issuer LLC (the Co-Issuer), a communications infrastructure securitization (CIS) that is primarily collateralized by fiber network assets and related contracts.
By Kroll Bond Rating Agency, LLC · Via Business Wire · October 6, 2025
agilon health Sets Date to Report Third Quarter 2025 Financial Results
agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced that it will release financial results for the third quarter 2025 after market close on Tuesday, November 4, 2025 and host a conference call at 4:30 p.m. ET to discuss the results.
By agilon health, inc. · Via Business Wire · October 6, 2025
NeuroOne Announces Preliminary Unaudited Product Revenue Growth of 163% to Record $9.1 Million, Invitation to Join Virtual Investor Webinar Tomorrow at 8:30 am EST
EDEN PRAIRIE, MINN. - October 6, 2025 ( NEWMEDIAWIRE ) - NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced preliminary unaudited product revenue for the fiscal year ended September 30, 2025.
Via TheNewswire.com · October 6, 2025
NeuroOne Announces Preliminary Unaudited Product Revenue Growth of 163% to Record $9.1 Million, Invitation to Join Virtual Investor Webinar Tomorrow at 8:30 am EST
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · October 6, 2025
ClearPoint Neuro Announces Expanded International Clearances for Key Therapy Delivery Product; Now Totaling 34 Countries Worldwide
The clearly established history across global regulatory bodies is expected to de-risk BioPharma partners' pathways towards achieving global scale and standardization.
Via ACCESS Newswire · October 6, 2025
Morgan Stanley Direct Lending Fund Announces Third Quarter 2025 Earnings Release and Conference Call
Morgan Stanley Direct Lending Fund (NYSE: MSDL) ("MSDL”), a business development company externally managed by MS Capital Partners Adviser Inc., today announced it will release its financial results for the quarter ended September 30, 2025, on Thursday, November 6, 2025, after the market closes. MSDL will host a conference call at 10:00 am ET on Friday, November 7, 2025, to review its financial results and conduct a question-and-answer session.
Broadstone Net Lease Schedules Third Quarter 2025 Earnings Release and Conference Call
Broadstone Net Lease, Inc. (NYSE: BNL) (“Broadstone,” “BNL,” the “Company,” “we,” “our,” or “us”), today announced that it will release its financial and operating results for the quarter ended September 30, 2025, after the market closes on Wednesday, October 29, 2025. The Company will host its earnings conference call and audio webcast on Thursday, October 30, 2025, at 11:00 a.m. Eastern Time.
By Broadstone Net Lease, Inc. · Via Business Wire · October 6, 2025
Independent Bank Corp.’s Announcement of Date of Third Quarter Conference Call
Independent Bank Corp. (Nasdaq Global Select Market: INDB), parent of Rockland Trust Company, will host its quarterly conference call to discuss third quarter results on Friday, October 17, 2025, at 10:00 AM Eastern Time. Telephonic access will be available by dial-in at 888-336-7153 reference: INDB. Participants may also choose to pre-register for the conference by navigating to https://dpregister.com/sreg/10203638/1001737c342 which will provide a unique PIN to the participant which allows immediate access to the call. A replay of the call will be available by calling 877-344-7529, Replay Conference Number: 5617042 which will be available through October 24, 2025.
By Independent Bank Corp. · Via Business Wire · October 6, 2025
Alloy Roofing Partners with IBEX Roof in Ridgefield, WA
Alloy Roofing, a growing platform for best-in-class roofing services companies with the Branch Support Center located in Atlanta, Georgia, announced today the successful partnership with IBEX Roof, a leading residential roofing company based in Ridgefield, Washington. Founded in 2015 by industry veteran Kirk Koskiniemi, IBEX serves customers across Washington and Oregon with reroof, service, gutter, and insulation offerings.
By Alloy Roofing · Via Business Wire · October 6, 2025
SAIC to Acquire SilverEdge Government Solutions
Move bolsters SAIC’s leading role of bringing commercial-grade technologies and solutions to advance national security missions and operations
By SAIC, Inc. · Via GlobeNewswire · October 6, 2025
Constellation Brands Reports Second Quarter Fiscal 2026 Financial Results
ROCHESTER, N.Y., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Constellation Brands, Inc. (NYSE: STZ), a leading beverage alcohol company, reported today its second quarter fiscal 2026 financial results. A conference call to discuss the financial results and outlook will be hosted by President and Chief Executive Officer, Bill Newlands, and Chief Financial Officer, Garth Hankinson, on Tuesday, October 7, 2025 at 8:00 a.m. ET. Visit ir.cbrands.com to locate information for joining the conference call, or a live, listen-only webcast of the conference call.
By Constellation Brands, Inc. · Via GlobeNewswire · October 6, 2025
Rambus to Announce Third Quarter Fiscal Year 2025 Results
Rambus Inc. (Nasdaq: RMBS), a provider of industry-leading chips and IP making data faster and safer, today announced that it will hold a conference call on Monday, October 27, 2025, at 2:00 p.m. Pacific Time to discuss its third quarter fiscal year 2025 results.
By Rambus Inc. · Via Business Wire · October 6, 2025
AEye Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
AEye, Inc. (Nasdaq: LIDR), a global leader in software-defined, high-performance lidar solutions, today announced the grant of an inducement equity award to its newly appointed Vice President Software and Systems Engineering, Andreas Dellantonio. The grant was approved by the Compensation Committee of the Company’s Board of Directors as a material inducement to Mr. Dellantonio entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4).
By AEye, Inc. · Via Business Wire · October 6, 2025
Light & Wonder to Report Third Quarter 2025 Results on Wednesday, November 5, 2025
Light & Wonder, Inc. (NASDAQ and ASX: LNW) (“Light & Wonder” or the “Company”), announced today that it will release its financial results for the third quarter of 2025, on Wednesday, November 5, 2025, after the U.S. markets close, and before the ASX opens on Thursday, November 6, 2025. The Company will host an investor conference call and simultaneous webcast the same day at 4:30 p.m. U.S. Eastern Time and 8:30 a.m. Australian Daylight Savings Time to discuss the results.
By Light & Wonder, Inc. · Via Business Wire · October 6, 2025
Sabra Health Care REIT, Inc. to Attend the AHCA/NCAL Convention & Expo
Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Talya Nevo-Hacohen, the company’s Chief Investment Officer, Kara Pappanduros, the company’s Senior Vice President of Asset Management, and other members of the company, will attend the AHCA/NCAL Convention & Expo, Delivering Solutions 25 on October 19-22, 2025, at the South Convention Center of the Mandalay Bay Resort & Casino in Las Vegas, Nevada. Ms. Nevo-Hacohen will participate in an Investment Solutions panel on October 21st.
By Sabra Health Care REIT, Inc. · Via Business Wire · October 6, 2025
Aehr Test Systems Reports Fiscal 2026 First Quarter Financial Results; Strong AI and Data Center-Related Semiconductor Test and Burn-in Activity Underscores Multi-Year Market Opportunity
FREMONT, CA, CA / ACCESS Newswire / October 6, 2025 / Aehr Test Systems (NASDAQ:AEHR), a worldwide supplier of semiconductor test and burn-in equipment, today announced financial results for its first quarter of fiscal 2026 ended August 29, 2025.
Via ACCESS Newswire · October 6, 2025
StoneCo Ltd. to Announce Third Quarter 2025 Financial Results on November 06th, 2025
George Town, Grand Cayman--(Newsfile Corp. - October 6, 2025) -  StoneCo Ltd. (NASDAQ: STNE) ("Stone") today announces that it will...
Via Newsfile · October 6, 2025
Ameresco Secures $197M Energy Infrastructure Project With U.S. Naval Research Laboratory
Ameresco, Inc., (NYSE: AMRC), a leading energy solutions provider dedicated to helping customers navigate the energy transition, today announced a collaboration with the U.S. Naval Research Laboratory (NRL) to execute a $197 million Energy Savings Performance Contract (ESPC) through the U.S. Army Engineering Support Center (USACE), Huntsville (Huntsville Center) ESPC III Multiple Award Task Order Contract (MATOC). This comprehensive initiative is designed to modernize critical infrastructure, strengthen utility resilience and generate substantial long-term cost savings across NRL’s Washington, D.C. campus and Chesapeake Bay Detachment.
By Ameresco, Inc. · Via Business Wire · October 6, 2025
Tredegar Announces the Retirement of D. Andrew Edwards, Chief Financial Officer and Executive Vice President, Effective December 31, 2025
Tredegar Corporation (NYSE:TG) today announced that D. Andrew Edwards, Tredegar’s Chief Financial Officer and Executive Vice President, will retire, effective December 31, 2025.
By Tredegar Corporation · Via Business Wire · October 6, 2025
Palmer Square Capital BDC Inc. Announces Third Quarter 2025 Earnings Release and Conference Call
Palmer Square Capital BDC Inc. (NYSE: PSBD) ("Palmer Square" or the "Company"), an externally managed business development company, today announced that it will release its financial results for the third quarter ended September 30, 2025, before the market opens on Wednesday, November 5, 2025. Palmer Square will host a conference call at 1:00 pm ET that day to review its financial performance and conduct a question-and-answer session.
By Palmer Square Capital BDC Inc. · Via Business Wire · October 6, 2025
Upstart to Announce Third Quarter 2025 Results on November 4, 2025
Upstart Holdings, Inc. (NASDAQ: UPST), the leading artificial intelligence (AI) lending marketplace, will hold a conference call to discuss its third quarter 2025 financial results on Tuesday, November 4, 2025, at 1:30 p.m. PT / 4:30 p.m. ET. The company’s earnings press release and investor presentation will be available on its investor relations website at ir.upstart.com after the market closes that day.
By Upstart Holdings, Inc. · Via Business Wire · October 6, 2025
SS&C to Release Third Quarter 2025 Earnings
SS&C Technologies Holdings, Inc. (Nasdaq: SSNC), a global provider of financial services and healthcare software and software-enabled services, will announce its financial results for the third quarter ended September 30, 2025 after the close of the market on Thursday, October 23, 2025. The earnings conference call, scheduled for Thursday, October 23, 2025 at 5:00 p.m. Eastern Time, will discuss third quarter 2025 results.
By SS&C · Via Business Wire · October 6, 2025
Confluent to Announce Third Quarter 2025 Financial Results on October 27, 2025
Confluent, Inc. (NASDAQ: CFLT), the data streaming pioneer, today announced it will release financial results for its third quarter of 2025, which ended September 30, 2025, after the U.S. market close on Monday, October 27, 2025. Confluent will host a live video webcast to discuss the results.
By Confluent, Inc. · Via Business Wire · October 6, 2025
Sprout Social to Announce Third Quarter 2025 Financial Results on November 5, 2025
CHICAGO, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Sprout Social, Inc. (“Sprout Social”, the “Company”) (Nasdaq: SPT), an industry-leading provider of cloud-based social media management software, today announced that it will report its financial results for the third quarter ending September 30, 2025 after market close on Wednesday, November 5, 2025.
By Sprout Social, Inc · Via GlobeNewswire · October 6, 2025
Crinetics Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 6, 2025
SAN DIEGO, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that it will report third quarter 2025 financial results on Thursday, November 6, 2025 after the market closes. Company management will host a conference call at 4:30 p.m. ET to discuss financial results and provide a business update.
By Crinetics Pharmaceuticals, Inc. · Via GlobeNewswire · October 6, 2025
Encore Capital Group to Announce Third Quarter 2025 Financial Results on November 5
SAN DIEGO, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Encore Capital Group, Inc. (Nasdaq:ECPG), an international specialty finance company, announced today that it will release its financial results for the third quarter 2025 on Wednesday, November 5, 2025, after the market closes. The Company will also host a conference call and slide presentation the same day at 2:00 p.m. Pacific / 5:00 p.m. Eastern time with Ashish Masih, President and Chief Executive Officer, Tomas Hernanz, Executive Vice President and Chief Financial Officer, and Bruce Thomas, Vice President, Global Investor Relations, presenting and discussing the reported results.
By Encore Capital Group, Inc. · Via GlobeNewswire · October 6, 2025
Immix Biopharma to Present Abstract at the upcoming ASH 2025 Annual Meeting
Los Angeles, CA, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), the global leader in relapsed/refractory AL Amyloidosis, today announced that it will present a NXC-201 abstract at the upcoming American Society of Hematology (ASH) 67th Annual Meeting and Exposition to be held December 6-9, 2025, in Orlando, Florida.
By Immix Biopharma, Inc. · Via GlobeNewswire · October 6, 2025
Biomea Fusion Announces Positive 52-Week Results from Phase II COVALENT-111 Study in Type 2 Diabetes Demonstrating Non-Chronic Treatment with Icovamenib Benefits Two Distinct Patient Populations
SAN CARLOS, Calif., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea” or “Biomea Fusion” or “the Company”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity company, today announced positive 52-week results from its Phase II COVALENT-111 study evaluating the efficacy, safety, and tolerability of icovamenib in patients with type 2 diabetes (T2D).
By Biomea Fusion, Inc. · Via GlobeNewswire · October 6, 2025
First Acceptance Corporation Announces Appointment of Two New Board Members
NASHVILLE, TN, AL / ACCESS Newswire / October 6, 2025 / First Acceptance Corporation (OTCQX:FACO) today announced the appointment of Craig Gentry and Raimundo Ruiz to its Board of Directors effective October 6, 2025. Mr. Gentry also will serve as a member of the Board's Audit Committee, while Mr. Ruiz also will serve as a member of the Board's Risk Committee. Following these appointments, the Company's Board will be comprised of nine directors, seven of whom are independent.
Via ACCESS Newswire · October 6, 2025
Planet and VITO Extend Long-Term Partnership to Accelerate Earth Observation Solutions for Agriculture and Environment
Planet Labs PBC (NYSE: PL), a leading provider of daily data and insights about Earth, and VITO, a leading European research and technology organization, today announced an extension to their long-term partnership to accelerate the use of Earth observation for global impact. By bringing together Planet’s daily, global satellite imagery and advanced solutions with VITO’s proven analytics and service platforms, the partners will deliver faster, more actionable insights for agriculture, global monitoring and environmental resilience.
By Planet · Via Business Wire · October 6, 2025
Veeco Launches Lumina+ MOCVD System, Receives Multi Tool Order for High-Volume Production of Compound Semiconductor Products
PLAINVIEW, N.Y., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Veeco Instruments Inc. (NASDAQ: VECO) today announced the launch and first commercial multi-tool order for its new Lumina+ metal-organic chemical vapor deposition (MOCVD) system. Rocket Lab Corporation (NASDAQ: RKLB), a global leader in launch services and space systems, purchased the tools as part of its ongoing project under the Department of Commerce’s CHIPS and Science Act to expand domestic production of compound semiconductor products. This high-volume manufacturing order reinforces Veeco’s leadership in the As/P field and marks a significant milestone for the company.
By Veeco Instruments Inc. · Via GlobeNewswire · October 6, 2025
MidCap Financial Investment Corporation Schedules Earnings Release and Conference Call for Quarter Ended September 30, 2025
NEW YORK, Oct. 06, 2025 (GLOBE NEWSWIRE) -- MidCap Financial Investment Corporation (NASDAQ: MFIC) (the “Company”) announced today that it will report results for the quarter ended September 30, 2025, after the closing of the Nasdaq Global Select Market on Thursday, November 6, 2025.
Octave Bioscience Awarded Valhalla Foundation Grant to Accelerate Development of the First MS Disease Progression Test
Octave Bioscience, Inc., a commercial-stage precision care company pioneering biomarker-driven solutions for multiple sclerosis (MS) and other neurodegenerative diseases, today announced that it is advancing development of the world’s first biomarker blood test for MS progression with support from the Valhalla Foundation.
By Octave Bioscience, Inc. · Via Business Wire · October 6, 2025
Yunqi Capital, One of STAAR Surgical Company’s Largest Shareholders, Reiterates Its Opposition to the Proposed Merger with Alcon
Yunqi Capital Limited (together with its affiliates and the funds it advises, “Yunqi Capital”), an investment management firm and 5.1% shareholder of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ:STAA), today released the following open letter reiterating its opposition to the proposed sale to Alcon Inc. (SIX/NYSE:ALC) on the terms announced on August 5, 2025.
By Yunqi Capital Limited · Via Business Wire · October 6, 2025
Dynex Capital, Inc. Schedules Third Quarter 2025 Earnings Release and Conference Call
Dynex Capital, Inc. (NYSE: DX) announced today that it will release its financial results for the third quarter of 2025 before market open and will host a conference call and live audio webcast to discuss its financial results at 10:00 a.m. ET on Monday, October 20, 2025.
By Dynex Capital, Inc. · Via Business Wire · October 6, 2025
Omnicell to Release Third Quarter 2025 Financial Results on October 30, 2025
Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy and nursing care delivery model, will release its financial results for the third quarter 2025, before market open on Thursday, October 30, 2025. The Company will host a conference call and webcast to discuss its financial results at 8:30 a.m. ET that same day.
By Omnicell, Inc. · Via Business Wire · October 6, 2025
Sanuwave Health Announces Preliminary Revenue Results for the Third Quarter 2025 (Ended September 30, 2025)
Sanuwave announces preliminary revenues of $11.4 million to $11.6 million for the third quarter ended September 30, 2025. This represents the highest quarterly revenues in Company history.
By SANUWAVE Health, Inc. · Via GlobeNewswire · October 6, 2025
Dorman Products, Inc. Announces Date to Report Third Quarter 2025 Financial Results
COLMAR, Pa., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Dorman Products, Inc. (the “Company” or “Dorman”) (NASDAQ: DORM) today announced the Company will report its financial results for the third quarter ended September 27, 2025, after the closing of the Nasdaq Stock Market on October 27, 2025.
By Dorman Products, Inc. · Via GlobeNewswire · October 6, 2025
Amlan Sponsors Networking Experience at LPN Congress & Expo 2025
CHICAGO, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Amlan is pleased to announce its participation in the 4th edition of the LPN Congress & Expo, taking place October 7–9, 2025 in Miami. This premier gathering for professionals in poultry production and animal nutrition across Latin America will serve as a focal point for innovation, knowledge exchange, and strategic partnership. 
By Oil-Dri Corporation Of America · Via GlobeNewswire · October 6, 2025
Heritage Global to Announce Third Quarter 2025 Results and Host Webcast on Thursday, November 6, 2025
Heritage Global Inc. (NASDAQ: HGBL) (“Heritage Global,” “HG” or “the Company”), an asset services company specializing in financial and industrial asset transactions, today announced that the Company will release its third quarter 2025 financial results after the market closes on Thursday, November 6, 2025.
By Heritage Global Inc. · Via Business Wire · October 6, 2025
Johnson & Johnson to Participate in the Guggenheim Securities 2nd Annual Healthcare Innovation Conference
Johnson & Johnson (NYSE: JNJ) will present at the Guggenheim Securities 2nd Annual Healthcare Innovation Conference on Tuesday, November 11th, 2025. Management will participate in a Fireside Chat at 10:30 a.m. Eastern Time.
By Johnson & Johnson · Via Business Wire · October 6, 2025
Wabtec Announces Third Quarter 2025 Earnings Release Date
Wabtec Corporation (NYSE: WAB) announced it will report 2025 third quarter results before the U.S. financial markets open on October 22, 2025. The company will conduct a conference call to discuss those results with analysts and investors at 8:30 a.m. ET the same day. To listen to the call via webcast, visit Wabtec’s website at www.WabtecCorp.com and click on “Events & Presentations” in the “Investor Relations” section. An audio replay of the call will be available by calling 1-877-344-7529 or 1-412-317-0088 (access code: 5713644).
By Wabtec Corporation · Via Business Wire · October 6, 2025
KalVista Pharmaceuticals Presents New Data Highlighting the Potential of EKTERLY® (sebetralstat) to Transform On-Demand Hereditary Angioedema Treatment in Europe
KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced new data from its KONFIDENT and KONFIDENT-S studies of EKTERLY® (sebetralstat), the first and only oral on-demand treatment for hereditary angioedema (HAE), presented at the 20th German Allergy Congress in Düsseldorf, Germany from October 2–4, 2025. Across multiple ePoster presentations, EKTERLY demonstrated the ability to rapidly halt the progression of HAE attacks, deliver fast symptom relief and address key barriers associated with injectable therapies. Additional survey findings from German patients further highlight the urgent need for access to innovative on-demand HAE treatments across Europe.
By KalVista Pharmaceuticals, Inc. · Via Business Wire · October 6, 2025
Vertex to Announce Third Quarter 2025 Financial Results on November 3rd
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its third quarter 2025 financial results on Monday, November 3, 2025, after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET. To access the call, please dial (833) 630-2124 (U.S.) or +1 (412) 317-0651 (International) and reference the “Vertex Pharmaceuticals Third Quarter 2025 Earnings Call.”
Stanislav Kondrashov Wagner Moura Series: Uncovering the Art Behind the Actor
Stanislav Kondrashov Wagner Moura Series: Uncovering the Art Behind the Actor
Via Get News · October 6, 2025